
Glupast Tablet 10mg (Mitiglinide Calcium Hydrate)
10mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.
Mitiglinide calcium hydrate is a diabetes treatment ingredient that helps lower blood sugar after meals.
MFDS ingredient code M252108
Mitiglinide calcium hydrate is a drug that stimulates insulin secretion and belongs to a class of diabetes treatments used for blood sugar control. It is mainly prescribed to lower blood sugar levels that rise sharply after meals.
This ingredient acts on the beta cells of the pancreas to rapidly increase insulin secretion. As a result, post-meal blood sugar is effectively controlled, reducing blood sugar spikes.
Approved uses differ by product. Check each product's information for its actual use.
Mitiglinide calcium hydrate is similar to the sulfonylurea class but has a short duration of action, making it characteristic for dosing just before meals. This reduces the risk of hypoglycemia while being specialized for post-meal blood sugar control.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.